Insider Selling: Phreesia, Inc. (NYSE:PHR) CFO Sells 948 Shares of Stock

Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi sold 948 shares of the firm’s stock in a transaction on Monday, April 15th. The shares were sold at an average price of $22.86, for a total value of $21,671.28. Following the completion of the transaction, the chief financial officer now owns 97,230 shares of the company’s stock, valued at approximately $2,222,677.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Balaji Gandhi also recently made the following trade(s):

• On Monday, April 8th, Balaji Gandhi sold 7,778 shares of Phreesia stock. The shares were sold at an average price of $22.62, for a total value of $175,938.36.
• On Monday, March 25th, Balaji Gandhi sold 3,504 shares of Phreesia stock. The shares were sold at an average price of $23.21, for a total value of $81,327.84.

Phreesia Stock Performance

PHR opened at $21.67 on Friday. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.78 and a current ratio of 1.78. The business has a 50-day moving average of $24.28 and a two-hundred day moving average of $21.28. Phreesia, Inc. has a 12 month low of $12.05 and a 12 month high of $34.98.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Thursday, March 14th. The company reported ($0.56) EPS for the quarter, beating the consensus estimate of ($0.58) by $0.02. The company had revenue of $95.00 million during the quarter, compared to analysts’ expectations of $93.52 million. Phreesia had a negative return on equity of 53.33% and a negative net margin of 38.42%. The firm’s revenue was up 24.0% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.72) EPS. Sell-side analysts anticipate that Phreesia, Inc. will post -1.48 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on PHR shares. Truist Financial started coverage on Phreesia in a research report on Monday, February 26th. They issued a “buy” rating and a $35.00 price target for the company. DA Davidson restated a “neutral” rating and issued a $32.00 price target on shares of Phreesia in a research report on Friday, March 15th. Stephens restated an “overweight” rating and issued a $28.00 price target on shares of Phreesia in a research report on Friday, March 22nd. Royal Bank of Canada reiterated a “sector perform” rating and set a $23.00 price objective on shares of Phreesia in a research report on Thursday, March 21st. Finally, Raymond James reiterated an “outperform” rating and set a $30.00 price objective (up previously from $25.00) on shares of Phreesia in a research report on Friday, March 15th. Two analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $31.62.

Institutional Trading of Phreesia

Several hedge funds and other institutional investors have recently added to or reduced their stakes in PHR. International Assets Investment Management LLC grew its holdings in Phreesia by 1,987.3% in the 4th quarter. International Assets Investment Management LLC now owns 1,482 shares of the company’s stock valued at $34,000 after buying an additional 1,411 shares during the period. Captrust Financial Advisors lifted its stake in shares of Phreesia by 154.6% in the 2nd quarter. Captrust Financial Advisors now owns 1,426 shares of the company’s stock valued at $36,000 after purchasing an additional 866 shares in the last quarter. Acadian Asset Management LLC acquired a new position in shares of Phreesia in the 1st quarter valued at about $43,000. State of Wyoming lifted its stake in shares of Phreesia by 34.6% in the 2nd quarter. State of Wyoming now owns 1,918 shares of the company’s stock valued at $59,000 after purchasing an additional 493 shares in the last quarter. Finally, Tower Research Capital LLC TRC lifted its stake in shares of Phreesia by 85.4% in the 3rd quarter. Tower Research Capital LLC TRC now owns 3,137 shares of the company’s stock valued at $80,000 after purchasing an additional 1,445 shares in the last quarter. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.